Meet our team

Stablepharma was set up to commercialise the ground breaking StablevaX™ product and in the process solve a major issue for world health.

The multi-disciplined team share a common passion and drive to see this invention in production to improve the effectiveness of global vaccination programmes and save lives.

The Executive team is supported by an Advisory Board formed during 2018 (Prof. Alan Boyd, Dr. Gunther Faber and Laura Murphy) all with a track record of successfully commercialising healthcare businesses.